A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy

NCT06285370 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Cutaneous T-Cell Lymphoma

Interventions

DRUG: Mogamulizumab

Sponsor

Kyowa Kirin China Pharmaceutical Co., Ltd.